Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 18,624 | 22,151 | 19,279 | 18,551 | 21,288 |
| Operating Income | -18,624 | -22,151 | -19,279 | -18,551 | -21,288 |
| Other Income | 37 | 51 | 704 | 710 | 989 |
| Pre-tax Income | -18,587 | -22,100 | -18,575 | -17,841 | -20,299 |
| Net Income Continuous | -18,587 | -22,100 | -18,575 | -17,841 | -20,299 |
| Net Income | $-18,587 | $-22,100 | $-18,575 | $-17,841 | $-20,299 |
| EPS Basic Total Ops | -0.55 | -0.66 | -0.56 | 0.71 | -0.62 |
| EPS Basic Continuous Ops | -0.55 | -0.66 | -0.56 | 0.71 | -0.62 |
| EPS Diluted Total Ops | -0.55 | -0.66 | -0.56 | 0.71 | -0.62 |
| EPS Diluted Continuous Ops | -0.55 | -0.66 | -0.56 | 0.71 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.66 | -0.56 | -0.53 | -0.62 |
| EBITDA(a) | $-18,435 | $-22,025 | $-19,168 | $-18,487 | $-21,180 |